● Synopsis (100 words or less): Cardiovascular (CV) events are an increasingly common
limitation of effective anticancer therapy. Over the last decade imaging has become …

Advances in cancer therapeutics have led to dramatic improvements in survival, now
inclusive of nearly 20 million patients and rising. However, cardiovascular toxicities …

The field of cardio-oncology, meant to ensure the cardiovascular safety of the most effective
cancer therapies during active cancer treatments and in the survival phase of care, has …

The world of cardio-oncology is an evolving field involving the assessment of cardiovascular
disease in patients suffering from cancer. Cancer and cardiovascular diseases are the two …

Based on currently available estimates, there are 13.7 million patients with a history of
cancer in the United States who are either cancer free or undergoing treatment, and about …

Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection
of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position …

The cardiovascular imaging assessment of cancer patients is driven by concerns regarding
cardio toxicity of chemotherapeutic agents, specific infiltrative cardiomyopathies such as …

Opinion statement Recent advances in cancer treatment and research have greatly
improved survival rates for patients with cancer. However, many of these cancer survivors …

This paper aims to empower and inform cardio-oncologists by providing a practical guide to
the clinical application of cardiac magnetic resonance (CMR) in the rapidly evolving field of …

Cardiotoxicity represents a rising problem influencing prognosis and quality of life of
chemotherapy‐treated patients. Anthracyclines and trastuzumab are the drugs most …